HK1198936A1 - Prevention of hiv-infection by using tmc278 tmc278 hiv - Google Patents

Prevention of hiv-infection by using tmc278 tmc278 hiv

Info

Publication number
HK1198936A1
HK1198936A1 HK14112581.4A HK14112581A HK1198936A1 HK 1198936 A1 HK1198936 A1 HK 1198936A1 HK 14112581 A HK14112581 A HK 14112581A HK 1198936 A1 HK1198936 A1 HK 1198936A1
Authority
HK
Hong Kong
Prior art keywords
tmc278
hiv
infection
prevention
tmc278 tmc278
Prior art date
Application number
HK14112581.4A
Other languages
English (en)
Chinese (zh)
Inventor
Lieven Elvire Colette Baert
Paulus Joannes Lewi
Jan Heeres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1198936A1 publication Critical patent/HK1198936A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK14112581.4A 2005-04-04 2014-12-16 Prevention of hiv-infection by using tmc278 tmc278 hiv HK1198936A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05102616 2005-04-04

Publications (1)

Publication Number Publication Date
HK1198936A1 true HK1198936A1 (en) 2015-06-19

Family

ID=34939113

Family Applications (2)

Application Number Title Priority Date Filing Date
HK08107189.8A HK1117039A1 (en) 2005-04-04 2008-06-27 Prevention of hiv-infection with tmc278
HK14112581.4A HK1198936A1 (en) 2005-04-04 2014-12-16 Prevention of hiv-infection by using tmc278 tmc278 hiv

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK08107189.8A HK1117039A1 (en) 2005-04-04 2008-06-27 Prevention of hiv-infection with tmc278

Country Status (29)

Country Link
US (6) US20080194601A1 (xx)
EP (1) EP1881848B1 (xx)
JP (2) JP5632579B2 (xx)
KR (1) KR101360851B1 (xx)
CN (2) CN101155599A (xx)
AP (1) AP2617A (xx)
AR (1) AR053571A1 (xx)
AU (1) AU2006231585B2 (xx)
BR (1) BRPI0607649B8 (xx)
CA (1) CA2602231C (xx)
CY (1) CY1113950T1 (xx)
DK (1) DK1881848T3 (xx)
EA (1) EA011420B1 (xx)
ES (1) ES2402864T3 (xx)
HK (2) HK1117039A1 (xx)
HR (1) HRP20130296T1 (xx)
IL (1) IL184744A (xx)
ME (1) ME01517B (xx)
MX (1) MX2007012277A (xx)
MY (1) MY150091A (xx)
NZ (1) NZ556659A (xx)
PL (1) PL1881848T3 (xx)
PT (1) PT1881848E (xx)
RS (1) RS52724B (xx)
SI (1) SI1881848T1 (xx)
TW (2) TW201414495A (xx)
UA (1) UA90124C2 (xx)
WO (1) WO2006106103A2 (xx)
ZA (1) ZA200708454B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
TW201414495A (zh) * 2005-04-04 2014-04-16 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
MY150717A (en) * 2006-01-20 2014-02-28 Tibotec Pharm Ltd Long term treatment of hiv-infection with tmc278
AR061620A1 (es) * 2006-06-23 2008-09-10 Tibotec Pharm Ltd Suspensiones acuosas de tmc278
TWI494133B (zh) 2007-03-14 2015-08-01 Tibotec Pharm Ltd 重組用粉末
SG196774A1 (en) * 2008-12-24 2014-02-13 Tibotec Pharm Ltd Implantable devices for treating hiv
SG181759A1 (en) * 2009-12-21 2012-07-30 Janssen R & D Ireland Degradable removable implant for the sustained release of an active compound
DE102011082871A1 (de) * 2011-09-16 2013-03-21 Florian, Prof. Dr. Lang Therapeutische und diagnostische Targets für Autoimmunität, inflammatorische Prozesse und/oder immuner Pathogenese und/oder von Erkrankungen, welche auf Autoimmunität, inflammatorische Prozessen und/oder immuner Pathogenese beruhen
JO3387B1 (ar) 2011-12-16 2019-03-13 Glaxosmithkline Llc مشتقات بيتولين
EA201590862A1 (ru) 2012-12-14 2016-05-31 ГЛАКСОСМИТКЛАЙН ЭлЭлСи Фармацевтические композиции
PE20170691A1 (es) * 2014-09-26 2017-06-13 Glaxosmithkline Intellectual Property (No 2) Ltd Composiciones farmaceuticas de accion prolongada
WO2022079739A1 (en) 2020-10-14 2022-04-21 Cipla Limited Fixed dose compositions of cabotegravir and rilpivirine

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06316524A (ja) 1992-09-11 1994-11-15 Naoyuki Inoue 抗エイズウイルス剤
US6258932B1 (en) 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
RU2239435C2 (ru) 2000-03-30 2004-11-10 Бристол-Маерс Сквибб Компани Гранулы пролонгированного высвобождения, содержащие ставудин
US20040115268A1 (en) * 2000-04-26 2004-06-17 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
MY169670A (en) * 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
US20050287177A1 (en) 2002-11-08 2005-12-29 Glaxo Group Unlimited And Smithkline Beecham Corp. Pharmaceutical compositions
ES2477118T3 (es) 2002-11-18 2014-07-15 Polaris Group Método para inhibir la replicaci�n viral in vivo
CL2004000192A1 (es) 2003-02-07 2005-03-18 Janssen Pharmaceutica Nv Uso de compuestos derivados de 2-aminopirimidina para preparar un medicamento para la prevencion de una infeccion por vih relaciones sexuales o un contacto intimo en la pareja.
JP2006518373A (ja) 2003-02-21 2006-08-10 トリペップ アクチ ボラゲット Ｈｉｖ複製を抑制するためのグリシンアミド誘導体
TW201414495A (zh) * 2005-04-04 2014-04-16 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
MY150717A (en) * 2006-01-20 2014-02-28 Tibotec Pharm Ltd Long term treatment of hiv-infection with tmc278
AR061620A1 (es) * 2006-06-23 2008-09-10 Tibotec Pharm Ltd Suspensiones acuosas de tmc278

Also Published As

Publication number Publication date
US10765674B2 (en) 2020-09-08
AP2617A (en) 2013-03-18
HRP20130296T1 (hr) 2013-04-30
EA200702169A1 (ru) 2008-02-28
KR101360851B1 (ko) 2014-02-11
TWI457136B (zh) 2014-10-21
PL1881848T3 (pl) 2013-06-28
EA011420B1 (ru) 2009-02-27
HK1117039A1 (en) 2009-01-09
CY1113950T1 (el) 2016-07-27
US20160151276A1 (en) 2016-06-02
CN103860560A (zh) 2014-06-18
US20110077261A1 (en) 2011-03-31
BRPI0607649B1 (pt) 2019-08-06
NZ556659A (en) 2012-03-30
ZA200708454B (en) 2009-03-25
SI1881848T1 (sl) 2013-05-31
JP2013079275A (ja) 2013-05-02
IL184744A0 (en) 2007-12-03
US20220071997A1 (en) 2022-03-10
JP2008534651A (ja) 2008-08-28
DK1881848T3 (da) 2013-04-15
BRPI0607649B8 (pt) 2021-05-25
TW200709818A (en) 2007-03-16
CA2602231C (en) 2014-03-25
RS52724B (en) 2013-08-30
UA90124C2 (ru) 2010-04-12
JP5632579B2 (ja) 2014-11-26
TW201414495A (zh) 2014-04-16
BRPI0607649A2 (pt) 2009-09-22
MX2007012277A (es) 2007-10-17
US20160296519A1 (en) 2016-10-13
US20080194601A1 (en) 2008-08-14
AP2007004178A0 (en) 2007-10-31
ME01517B (me) 2014-04-20
US20200397783A1 (en) 2020-12-24
MY150091A (en) 2013-11-29
WO2006106103A2 (en) 2006-10-12
AU2006231585A1 (en) 2006-10-12
ES2402864T3 (es) 2013-05-09
WO2006106103A3 (en) 2007-06-07
PT1881848E (pt) 2013-04-15
KR20080009051A (ko) 2008-01-24
EP1881848B1 (en) 2013-01-16
CA2602231A1 (en) 2006-10-12
AR053571A1 (es) 2007-05-09
CN101155599A (zh) 2008-04-02
EP1881848A2 (en) 2008-01-30
AU2006231585B2 (en) 2012-02-02
IL184744A (en) 2015-05-31

Similar Documents

Publication Publication Date Title
HK1198936A1 (en) Prevention of hiv-infection by using tmc278 tmc278 hiv
IL180959A0 (en) Hiv inhibiting 5-heterocyclyl pyrimidines
ZA200802723B (en) Modified 4'-nucleosides as antiviral agents
IL193610A (en) 5-Amino pyrimidines are converted from HIV virus inhibitors
ZA200702655B (en) HIV inhibiting 5-carbo- or heterocyclic substituted pyrimidines
PL2213168T3 (pl) Pestycydowe kombinacje substancji czynnych
AP2936A (en) Long term treatment of HIV-infection with TMC278
IL189261A0 (en) Pesticide pyrimidinyloxy substituted phenylamidine derivatives
EP1746141A4 (en) COMPOSITION FOR THICKENING
ZA200702656B (en) HIV inhibiting 5-substituted pyrimidines
EP1880677A4 (en) ULTRASONOGRAPH
DE602006006719D1 (en) Isothermer chemischer reaktor
IL176938A0 (en) Cytotoxicity assay
EP1786433A4 (en) BETULINOL DERIVATIVES AS ANTI-HIV MEDIUM
ZA200805177B (en) Aqueous rodenticide formulations
ZA200802536B (en) Niobium compound
ZA200709605B (en) HIV vaccine
GB2436054B (en) Biocidal Compositions
ZA200705410B (en) Prodrugs of 2,4-pyrimidinediamine compounds and their uses
GB0504770D0 (en) HIV Vif
GB0510888D0 (en) Hiv vif
GB0503775D0 (en) The compound used in the treatment of HIV
ITMI20042043A1 (it) Composti dotati di attivita' anti-hiv
ITBA20050017U1 (it) Rolle' hoplat "lo svuotafrigo"
HK1143151A1 (en) 2-2'-bis-thiazole derivatives as antiviral agents